Protein-based tools for the detection and characterisation of Oropouche virus infection

Oropouche fever is a neglected tropical disease caused by the orthobunyavirus Oropouche virus (OROV). A recent OROV epidemic caused by a novel reassortant has seen infections across an expanded geographical range, with deaths of healthy adults plus vertical transmission leading to pregnancy loss. OROV research and epidemiology is hampered by a paucity of available tools for serology and molecular virology. We have purified recombinant OROV nucleoprotein and the spike region of the viral surface glycoprotein Gc. These antigens detect seroconversion following experimental infection of animals in indirect ELISA, confirming their antigenic authenticity. They stimulate the production of high neutralising antibody titres in animals, highlighting their promise as immunogens for vaccination. We developed a nanobody-based sandwich ELISA that can detect OROV antigens in human clinical serum samples with high efficiency, and we show that nanobodies directed against OROV Gc spike can potently neutralise infection by both historical OROV strains and the newly emerged reassortant. Our protein-based reagents will accelerate OROV research and highlight the utility of protein-based tools for future OROV vaccines and point-of-care diagnostic devices.

Authors

Institutions

Publication Details

Journal
EMBO Molecular Medicine
Published
2025-08-11
DOI
https://doi.org/10.1038/s44321-025-00291-7
Citations
3
Primary Topic
Plant Virus Research Studies
Type
article
Field-Weighted Citation Impact
5.25

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Protein-based tools for the detection and characterisation of Oropouche virus infection

M. Silva, Raymond J. Owens, Jared S. Rudd, Daniel Macedo de Melo Jorge et al.
3 citations
EMBO Molecular Medicine
Plant Virus Research Studies
5.25
article

Protein-based tools for the detection and characterisation of Oropouche virus infection

M. Silva, Raymond J. Owens, Jared S. Rudd, Daniel Macedo de Melo Jorge, Sahar Abdelkarim, Felipe Gomes Naveca, Isa Cristina Ribeiro Piauilino, Eve R. Caroe, Luana Cristina Cavalcante Madeiro dos Santos Silva, José Luiz Proença‐Módena, Regina Maria Pinto de Figueiredo, Sérgio Damasceno Pinto, Felipe Rocha do Nascimento, Eurico Arruda, Stephen C. Graham, Lauren Eyssen, Monique Merchant, Juliano de Paula Souza, Valdinete Alves do Nascimento, Shrestha Chakraborty, T Nasser, Yuxian Sun, Kristel Irma Gutierrez Manchay
article en
3 citations

Abstract

Oropouche fever is a neglected tropical disease caused by the orthobunyavirus Oropouche virus (OROV). A recent OROV epidemic caused by a novel reassortant has seen infections across an expanded geographical range, with deaths of healthy adults plus vertical transmission leading to pregnancy loss. OROV research and epidemiology is hampered by a paucity of available tools for serology and molecular virology. We have purified recombinant OROV nucleoprotein and the spike region of the viral surface glycoprotein Gc. These antigens detect seroconversion following experimental infection of animals in indirect ELISA, confirming their antigenic authenticity. They stimulate the production of high neutralising antibody titres in animals, highlighting their promise as immunogens for vaccination. We developed a nanobody-based sandwich ELISA that can detect OROV antigens in human clinical serum samples with high efficiency, and we show that nanobodies directed against OROV Gc spike can potently neutralise infection by both historical OROV strains and the newly emerged reassortant. Our protein-based reagents will accelerate OROV research and highlight the utility of protein-based tools for future OROV vaccines and point-of-care diagnostic devices.

EMBO Molecular MedicineVol. 17(9)
Universidade de Ribeirão Preto (BR), Centre for Human Genetics (GB), Universidade de São Paulo (BR), Universidade Estadual de Campinas (UNICAMP) (BR), University of Cambridge (GB), Fundação de Medicina Tropical (BR), Rosalind Franklin Institute (GB), Secretaria do Meio Ambiente (BR), Universidade do Estado do Amazonas (BR), Clinics Hospital of Ribeirão Preto (BR), Fundação Oswaldo Cruz (BR), Universidade Federal do Amazonas (BR)
Royal Society, Fundação de Amparo à Pesquisa do Estado de São Paulo, Universidade de São Paulo, Directorate for Biological Sciences, Biotechnology and Biological Sciences Research Council, Research England
Good health and well-being
Openalex Percentile: Top 5%
Plant Virus Research Studies
5.25
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.